Squeem, LLC – Trademark Portfolio

Entity Type: 16

Squeem, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SQUEEM. The owner is based in Orlando, FL.

6753 Kingspointe Pkwy, ste 110

6753

Orlando, FL 32819

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MUST
MUST
Abandoned 2018
DIVAFIT
DIVAFIT
Cancelled 2013
CONTAME
CONTAME
Cancelled 2004
SQUEEM
SQUEEM
Registered 1999

Trademark Classifications

Squeem, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (4 filings)

Clothing, footwear, headgear

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Squeem, LLC have?

Squeem, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 2 cancelled.

What trademark classes does Squeem, LLC file in?

Squeem, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 35 (Advertising & Business), Class 10 (Medical Apparatus). Class 25 covers clothing, footwear, headgear.

What are Squeem, LLC's most well-known trademarks?

Squeem, LLC's registered trademark portfolio includes well-known marks such as SQUEEM. These are among 1 currently registered trademark in the portfolio.

What is Squeem, LLC's trademark registration success rate?

Squeem, LLC has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.